Published on in Vol 13 (2025)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/64979, first published
.
Interpretable Machine Learning Model for Predicting and Assessing the Risk of Diabetic Nephropathy: Prediction Model Study
Interpretable Machine Learning Model for Predicting and Assessing the Risk of Diabetic Nephropathy: Prediction Model Study
Journals
- Li Q, Cheng M, Zhang X. Review on the Gut‐Kidney Axis Mechanism and Therapeutic Strategies in Diabetic Nephropathy. Diabetes/Metabolism Research and Reviews 2026;42(1) View
- Ajith T. Emerging Biomarkers in Diabetic Kidney Disease: The Necessity for Future Validation Studies, Mechanistic Investigation, and Integration into Risk Models. Journal of Advanced Health Research & Clinical Medicine 2025;2(2):41 View
- Li D, Liu X, Zhang L, Gong Q, Huang W, Xu Y. From the energy factory to the intercellular communication medium: the emerging role of intercellular mitochondrial transfer and mitochondrial transplantation therapy in diabetes and diabetic complications. Journal of Translational Medicine 2026;24(1) View
- Zhang M, Zhu S, Hu D, Fu W, Hu H, Xu Y, Zhang K, Tang H, Du X. Developing and validating a clinlabomics-based machine-learning model for early detection of occult diabetic kidney disease: implications for primary care screening. Frontiers in Endocrinology 2026;17 View
- Kang B, Oh R, Kim T, Yoo J, Kang D, Kim G, Jin S, Chung M, Kim J. Association of Variability of Monthly Continuous Glucose Monitoring‐Derived Metrics With Diabetic Kidney Disease in Type 1 Diabetes. Diabetes, Obesity and Metabolism 2026 View
Conference Proceedings
- Abid M, Morshed A, Kabir M, Polak M, Myisha N, Ghosh S. 2026 Second International Conference on Multi-Agent Systems for Collaborative Intelligence (ICMSCI). Cost-Aware Early Treatment Response Stratification in Non-Small Cell Lung Cancer Using Interpretable Machine Learning View